Media Coverage

ContraFect advancing new modality for antibiotic-resistant infections

BioTuesdays

View »

Lysins Unlimited: Phages’ Secret Weapon

Genetic Engineering & Biotechnology News

View »

The Virtuous Side of Viruses

Scientific American

View »

Pfizer Takes Stake in a Biotech Company Called ContraFect

Barron’s

View »

Lysin Plus Antibiotics: A Cure for Human Bacterial Infections?

Reuters

View »